Close Menu

Somalogic

Researchers led by the Harvard Stem Cell Institute and Brigham and Women's Hospital have identified a protein — GDF11 — using Somalogic's Somascan technology, that they showed can reverse features of age-related heart disease in mice.

British diagnostic tools provider Avacta plans to introduce a new high-density protein microarray platform for use in drug and biomarker discovery by the end of next year, CEO Alastair Smith told BioArray News this week.

Under its new Parkinson's Disease Biomarker Program, the National Institute of Neurological Disorders and Stroke has funded nine research teams, most of which involve proteomic approaches, to attempt to identify biomarkers that could be used as either predictive or prognostic too

NEW YORK (GenomeWeb News) – SomaLogic, New England Biolabs, and Gilead Sciences are suing Enzymatics in federal court for patent infringement.

Proteomics diagnostics firm Somalogic reported data this week supporting the utility of its blood-based 13-protein panel for the detection of malignant mesothelioma.

Quest Diagnostics has begun offering a test for measuring free epidermal growth factor receptor using Somalogic's aptamer-based Somamer technology.

Life Technologies said this week that it plans to accelerate development of its Ion Torrent technology for proteomic applications.

SomaLogic has released SomaSuite, a software tool that provides access to multiplexed proteomic data generated by SomaLogic's Somascan proteomics assay technology.

Aushon Biosystems announced this week its plans to launch a new multiplex protein biomarker platform.

By Adam Bonislawski
Somalogic last week published in PLoS One a study offering the first data on use of its aptamer-based Somascan platform in tissue samples.

Pages

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

One gene regulates hundreds of others to influence facial development, according to New Scientist.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.